Okey Stephanie
SEC Form 4 insider trading activity
Okey Stephanie has filed 8 SEC Form 4 filings (13 transaction rows) across 2 companies, including CRNX, PTCT, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.
On the most recent filing, Okey Stephanie is listed as Director at Crinetics Pharmaceuticals, Inc. Inside the rolling window, Okey Stephanie reported no open-market purchases and 4 open-market sales totaling $1.8M in CRNX and PTCT. The largest disclosed transaction in the window is a sale of 15,167 PTCT shares on Mar 10, 2026, worth $1.1M.
Companies traded
Other insiders at CRNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.8M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Okey Stephanie made?
Okey Stephanie has filed 8 SEC Form 4 filings (13 transaction rows) across 2 companies, including CRNX, PTCT since 2025.
Which companies does Okey Stephanie trade?
Okey Stephanie has filed SEC Form 4 disclosures for 2 companies, including CRNX, PTCT.
When was Okey Stephanie's most recent SEC Form 4 filing?
Okey Stephanie's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.
What is Okey Stephanie's total buy and sell value in the current window?
Inside the rolling retention window, Okey Stephanie bought $0 and sold $1.8M based on SEC Form 4 filings.
What was Okey Stephanie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,167 PTCT shares on 2026-03-10, worth $1.1M, per SEC Form 4 filings.